Janssen Pharmaceuticals, Inc.

Janssen Vaccines & Prevention B.v.

Janik Adriaansen

Wouter Frank Tonnis

Francesco Doro

Olga Labovitiadi

Renske Willemijn Hesselink

Compositions and methods for inducing an immune response against extra-intestinal pathogenic(ExPEC) are described. In particular, multivalent vaccines containing O-antigen polysaccharide covalently bound to an exotoxin A of(EPA) carrier protein that can withstand multiple environmental stresses are describe.

ExPEC glycoconjugate vaccine formulations

This disclosure provides pharmaceutical adenovirus formulations, in particular, liquid pharmaceutical formulations comprising adenoviruses.

Adenovirus formulations

Compositions and methods for inducing an immune response against extra-intestinal pathogenic(ExPEC) are described. In particular, multivalent vaccines containing O-antigen polysaccharide covalently bound to an exotoxin A of(EPA) carrier protein that can withstand multiple environmental stresses are described.

Compositions and methods for inducing an immune response against extra-intestinal pathogenic(ExPEC) are described. In particular, multivalent vaccines containingantigen polysaccharide covalently bound to a exotoxin A of(EPA) carrier protein that can withstand multiple environmental stresses are described.

Growing community of inventors

The Hague, Netherlands

Janik Adriaansen